跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MUCODIN SYRUP 250 MG/5 ML - HSA Drug Approval Details
Approvals
/
HSA
/
MUCODIN SYRUP 250 MG/5 ML
Approved
THERAPEUTIC
MUCODIN SYRUP 250 MG/5 ML
SUNWARD PHARMACEUTICAL PRIVATE LIMITED - SINGAPORESUNWARD PHARMACEUTICAL SDN BHD (MALAYSIA)
🇸🇬 Health Sciences Authority
Approval Date
May 31, 1989
Approval ID
42a28c4ec45f785c
Company
SUNWARD PHARMACEUTICAL PRIVATE LIMITED - SINGAPORESUNWARD PHARMACEUTICAL SDN BHD (MALAYSIA)
Type
Therapeutic
Approval Details
Approval Id
42a28c4ec45f785c
Drug Name
MUCODIN SYRUP 250 MG/5 ML
Product Name
MUCODIN SYRUP 250 MG/5 ML
Approval Number
SIN03003P
Approval Date
1989-05-31
Registrant
SUNWARD PHARMACEUTICAL PRIVATE LIMITED
Licence Holder
SUNWARD PHARMACEUTICAL PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
PHARMACY ONLY MEDICINES
Dosage Form
SYRUP
Route Of Administration
ORAL
Atc Code
R05CB03
Atc Item Name
carbocisteine
Pharma Manufacturer Name
SUNWARD PHARMACEUTICAL PRIVATE LIMITED
Company Detail Path
/organization/sunward-pharmaceutical-private-limited
Active Ingredients
CARBOCISTEINE
250 mg/5 ml
CARBOCISTEINE
250 mg/5 ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 31, 1989
Approval ID
42a28c4ec45f785c
Type
Therapeutic
Back to HSA Approvals